Literature DB >> 18056400

Selective proinflammatory activation of astrocytes by high-mobility group box 1 protein signaling.

Marco Pedrazzi1, Mauro Patrone, Mario Passalacqua, Elia Ranzato, Diego Colamassaro, Bianca Sparatore, Sandro Pontremoli, Edon Melloni.   

Abstract

Extracellular high-mobility group box 1 protein (HMGB1) triggers inflammatory events in the brain. We demonstrate that astrocytes, the main glial cells in the brain, acquire a specific reactive phenotype when exposed to HMGB1. This cell activation, which involves the receptor for advanced glycation end-products and the MAPK/ERK1/2 cascade, results in the transcriptional/translational induction of a restricted number of inflammatory mediators, including cyclooxygenase-2, matrix metalloproteinase-9, and several chemokines of the CC and CXC families. The mixture of factors released by HMGB1-reactive astrocytes displays a potent chemotactic activity on human monocytic cells. This study is the first to suggest that HMGB1/astrocyte interaction plays a specific functional role in the progression of inflammatory processes in the CNS by facilitating local leukocyte infiltration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18056400     DOI: 10.4049/jimmunol.179.12.8525

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  58 in total

1.  Macrophage activation by factors released from acetaminophen-injured hepatocytes: potential role of HMGB1.

Authors:  Ana-Cristina Dragomir; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2011-04-14       Impact factor: 4.219

Review 2.  Cytokines and brain excitability.

Authors:  Michael A Galic; Kiarash Riazi; Quentin J Pittman
Journal:  Front Neuroendocrinol       Date:  2011-12-27       Impact factor: 8.606

Review 3.  Immune players in the CNS: the astrocyte.

Authors:  Cathy J Jensen; Ann Massie; Jacques De Keyser
Journal:  J Neuroimmune Pharmacol       Date:  2013-07-04       Impact factor: 4.147

4.  HMGb1 promotes scratch wound closure of HaCaT keratinocytes via ERK1/2 activation.

Authors:  Elia Ranzato; Mauro Patrone; Marco Pedrazzi; Bruno Burlando
Journal:  Mol Cell Biochem       Date:  2009-07-09       Impact factor: 3.396

Review 5.  Proteomic identification of multitasking proteins in unexpected locations complicates drug targeting.

Authors:  Georgina S Butler; Christopher M Overall
Journal:  Nat Rev Drug Discov       Date:  2009-12       Impact factor: 84.694

Review 6.  Astrocyte roles in traumatic brain injury.

Authors:  Joshua E Burda; Alexander M Bernstein; Michael V Sofroniew
Journal:  Exp Neurol       Date:  2015-03-28       Impact factor: 5.330

7.  ADAMTS13 gene deletion enhances plasma high-mobility group box1 elevation and neuroinflammation in brain ischemia-reperfusion injury.

Authors:  Masayuki Fujioka; Takafumi Nakano; Kazuhide Hayakawa; Keiichi Irie; Yoshiharu Akitake; Yuya Sakamoto; Kenichi Mishima; Carl Muroi; Yasuhiro Yonekawa; Fumiaki Banno; Koichi Kokame; Toshiyuki Miyata; Kenji Nishio; Kazuo Okuchi; Katsunori Iwasaki; Michihiro Fujiwara; Bo K Siesjö
Journal:  Neurol Sci       Date:  2012-01-03       Impact factor: 3.307

Review 8.  The Biology of Regeneration Failure and Success After Spinal Cord Injury.

Authors:  Amanda Phuong Tran; Philippa Mary Warren; Jerry Silver
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

Review 9.  High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation.

Authors:  Shu Zhu; Wei Li; Mary F Ward; Andrew E Sama; Haichao Wang
Journal:  Inflamm Allergy Drug Targets       Date:  2010-03

Review 10.  The HMGB1-RAGE Inflammatory Pathway: Implications for Brain Injury-Induced Pulmonary Dysfunction.

Authors:  Daniel J Weber; Yohance M Allette; David S Wilkes; Fletcher A White
Journal:  Antioxid Redox Signal       Date:  2015-05-14       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.